We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content
Log in

Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

C57/BL6 mice were administered either 7.5 mg Fe2+/kg or vehicle (saline) postnatally on days 10–12 after birth. From 61 days of age onwards for 21 days, groups of mice were administered either clozapine (1 or 5 mg/kg, s.c.) or haloperidol (1 mg/kg, s.c.) or vehicle (Tween-80). Twenty-four hours after the final injection of either neuroleptic compound or vehicle, spontaneous motor activity was measured over a 60-min interval. Following this, each animal was removed, injected apomorphine (1 mg/kg, s.c.) and replaced in the same test chamber. It was found that postnatal administration of Fe2+ at the 7.5 mg/kg dose level reduced activity during the initial 20-min periods (0–20 and 20–40 min) and then induced hyperactivity during the final 20-min period over all three parameters of activity. Subchronic treatment with the higher, 5 mg/kg, dose of clozapine abolished or attenuated the hypoactivity in by postnatal Fe2+ during the 1st two 20-min periods over all three parameters of activity. Subchronic treatment with the higher, 5 mg/kg, dose of clozapine abolished or attenuated the hyperactivity in by postnatal Fe2+ during the 3rd and final 20-min period. Subchronic administration of haloperidol, without postnatal iron, increased the level of both locomotion (1st 20 min) and rearing (2nd 20 min) activity. Postnatal administration of Fe2+ at the 7.5 mg/kg dose increased the levels of both locomotion and rearing, but not total activity, following administration of apomorphine (1 mg/kg). Subchronic administration of clozapine, at both the 1 and 5 mg/kg doses, reduced the increased locomotor activity caused by postnatal Fe2+, whereas clozapine, 5 mg/kg, elevated further the postnatal Fe2+-induced increased in rearing. Subchronic administration of clozapine, at both the 1 and 5 mg/kg doses, and haloperidol, 1 mg/kg, increased the level of locomotor following administration of apomorphine (1 mg/kg) in mice treated postnatally with vehicle, whereas only clozapine increased the level of rearing. Correlational analyses indicated that both apomorphine-induced locomotion and rearing were highly correlated with the total iron content in the basal ganglia, thereby offering direct evidence of the linear relationship between iron content in the basal ganglia and the behavioural expression of DA D2-receptor supersensitivity in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • T Archer A Fredriksson G Jonsson T Lewander AK Mohammed SB Ross U Soderberg (1986) ArticleTitleCentral noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88 141–146 Occurrence Handle10.1007/BF00652230 Occurrence Handle1:CAS:528:DyaL28XitFyqurs%3D Occurrence Handle3081924

    Article  CAS  PubMed  Google Scholar 

  • T Archer N Schröder A Fredriksson (2003) ArticleTitleNeurobehavioural deficits following postnatal iron overload. II. Instrumental learning performance. Neurotox Res 5 77–94 Occurrence Handle1:STN:280:DC%2BD3srmtFWisQ%3D%3D Occurrence Handle14628858

    CAS  PubMed  Google Scholar 

  • D Ben-Shachar MB Youdim (1990) ArticleTitleNeuroleptic-induced supersensitivity and brain iron. I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity. J Neurochem 54 1136–1141 Occurrence Handle1:CAS:528:DyaK3cXhvFWkur8%3D Occurrence Handle1968955

    CAS  PubMed  Google Scholar 

  • D Ben-Shachar E Livne I Spanier R Zuk MB Youdim (1993) ArticleTitleIron modulates neuroleptic-induced effects related to the dopaminergic system. Isr J Med Sci 29 587–592 Occurrence Handle1:STN:280:ByuD2c3gtlA%3D Occurrence Handle7901181

    CAS  PubMed  Google Scholar 

  • D Ben-Shachar B Pinhassi MB Youdim (1991) ArticleTitlePrevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment. Eur J Pharmacol 202 177–183 Occurrence Handle10.1016/0014-2999(91)90292-X Occurrence Handle1:CAS:528:DyaK3MXmsVOqtL8%3D Occurrence Handle1687031

    Article  CAS  PubMed  Google Scholar 

  • RG Bolles PJ Woods (1964) ArticleTitleThe ontogeny of behaviour in the albino rat. Anim Behav 12 427–441 Occurrence Handle10.1016/0003-3472(64)90062-4

    Article  Google Scholar 

  • A Campbell RJ Baldessarini (1981) ArticleTitleTolerance to behavioural effects of haloperidol. Life Sci 29 1341–1346 Occurrence Handle10.1016/0024-3205(81)90677-9 Occurrence Handle1:CAS:528:DyaL3MXlvVSqu7g%3D Occurrence Handle7197320

    Article  CAS  PubMed  Google Scholar 

  • BA Campbell LD Lytle HC Fibiger (1969) ArticleTitleOntogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science 166 635–637 Occurrence Handle1:CAS:528:DyaE3cXhtFaksA%3D%3D Occurrence Handle5823302

    CAS  PubMed  Google Scholar 

  • Davison AN, Dobbing J (1968) Applied neurochemistry. Blackwell, Oxford, pp 178–221, 253–316

  • DT Dexter A Carayon F Javoy-Agid Y Agid FR Wells SE Daniel AJ Lees P Jenner CD Marsden (1991) ArticleTitleAlterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 1953–1975 Occurrence Handle1832073

    PubMed  Google Scholar 

  • DT Dexter FR Wells F Agid Y Agid AJ Lees P Jenner CD Marsden (1987) ArticleTitleIncreased nigral iron content in postmortem parkinsonian brain [letter]. Lancet 2 1219–1220 Occurrence Handle1:STN:280:BieD28vmtlI%3D Occurrence Handle2890848

    CAS  PubMed  Google Scholar 

  • BP Drayer W Olanow P Burger GA Johnson R Herfkens S Riederer (1986) ArticleTitleParkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159 493–498 Occurrence Handle1:STN:280:BimC2sfktlI%3D Occurrence Handle3961182

    CAS  PubMed  Google Scholar 

  • AJ Dwork G Lawler PA Zybert M Durkin M Osman N Willson AI Barkai (1990) ArticleTitleAn autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res 518 31–39 Occurrence Handle10.1016/0006-8993(90)90950-G Occurrence Handle1:CAS:528:DyaK3cXltFaqsb8%3D Occurrence Handle2390723

    Article  CAS  PubMed  Google Scholar 

  • PH Evans (1993) ArticleTitleFree radicals in brain metabolism and pathology. Br Med Bull 49 577–587 Occurrence Handle1:CAS:528:DyaK2cXltFaguw%3D%3D Occurrence Handle8221024

    CAS  PubMed  Google Scholar 

  • A Fredriksson N Schroder T Archer (2003) ArticleTitleNeurobehavioural deficits following postnatal iron overload. I. Spontaneous motor activity. Neurotoxicity Res 5 53–76 Occurrence Handle1:STN:280:DC%2BD3srmtFWisw%3D%3D

    CAS  Google Scholar 

  • A Fredriksson N Schroder P Eriksson I Izquierdo T Archer (1999) ArticleTitleNeonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159 25–30 Occurrence Handle10.1006/taap.1999.8711 Occurrence Handle1:CAS:528:DyaK1MXltFSgs70%3D Occurrence Handle10448122

    Article  CAS  PubMed  Google Scholar 

  • A Fredriksson N Schroder P Eriksson I Izquierdo T Archer (2000) ArticleTitleMaze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res 119 65–74 Occurrence Handle1:CAS:528:DC%2BD3cXltVCnug%3D%3D Occurrence Handle10648873

    CAS  PubMed  Google Scholar 

  • A Fredriksson N Schroder P Eriksson I Izquierdo T Archer (2001) ArticleTitleNeonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits. Parkinsonism Rel Dis 7 97–105

    Google Scholar 

  • M Gerlach D Ben-Shachar P Riederer MB Youdim (1994) ArticleTitleAltered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63 793–807 Occurrence Handle1:CAS:528:DyaK2cXlsFCgtLo%3D Occurrence Handle7519659

    CAS  PubMed  Google Scholar 

  • J Glowinski LL Iversen (1966) ArticleTitleRegional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13 655–669 Occurrence Handle1:CAS:528:DyaF28Xks1Kqtrw%3D Occurrence Handle5950056

    CAS  PubMed  Google Scholar 

  • MM Iqbal A Rahman Z Husain SZ Mahmud WG Ryan JM Feldman (2003) ArticleTitleClozapine: a clinical review of adverse effects and management. Ann Clin Psychiat 15 33–48

    Google Scholar 

  • Janetzky B, Reichmann H, Youdim MBH, Riederer P (1997) Iron and oxidative damage in neurodegenerative diseases. In: Beal MF, Howell H, Bodis-Wollner I (eds) Wiley-Liss, New York, pp 407–421

  • E Kienzl L Puchinger K Jellinger W Linert H Stachelberger RF Jameson (1995) ArticleTitleThe role of transition metals in the pathogenesis of Parkinson’s disease. J Neurol Sci 134 IssueIDSuppl 69–78 Occurrence Handle8847547

    PubMed  Google Scholar 

  • Kirk R (1995) Experimental design: procedures for the behavioural sciences. Brooks/Cole, Belmont, CA

  • P Laduron K De Bie J Leysen (1977) ArticleTitleSpecific effect of haloperidol on dopamine turnover in the frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 296 183–185 Occurrence Handle10.1007/BF00508472 Occurrence Handle1:CAS:528:DyaE2sXktFGqs78%3D Occurrence Handle834317

    Article  CAS  PubMed  Google Scholar 

  • JA Lieberman (1998) ArticleTitleMaximizing clozapine therapy: managing side effects. J Clin Psychiatry 59 38–43 Occurrence Handle1:CAS:528:DyaK1cXis1Srtro%3D Occurrence Handle9541337

    CAS  PubMed  Google Scholar 

  • DC Mash J Pablo BE Buck J Sanchez-Ramos WJ Weiner (1991) ArticleTitleDistribution and number of transferrin receptors in Parkinson’s disease and in MPTP-treated mice. Exp Neurol 114 73–81 Occurrence Handle10.1016/0014-4886(91)90086-R Occurrence Handle1:CAS:528:DyaK3MXmt12ls7o%3D Occurrence Handle1915737

    Article  CAS  PubMed  Google Scholar 

  • T Matsumoto H Uchimura M Hirano J Soo Kim H Yokoo M Shimomura T Nakahara K Inoue K Oomagari (1983) ArticleTitleDifferential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete levels of rat brain. Eur J Pharmacol 89 27–33 Occurrence Handle1:CAS:528:DyaL3sXktFKnurw%3D Occurrence Handle6861888

    CAS  PubMed  Google Scholar 

  • RG McKenzie MJ Zigmond (1985) ArticleTitleChronic neuroleptic treatment increased D-2 but not D-1 receptors in the rat striatum. Eur J Pharmacol 113 159–165

    Google Scholar 

  • HR Meltzer S Matsubara JC Lee (1989) ArticleTitleClassification of typical and atypical antipsychotic drugs on the basis of D1–D2 and serotonin PK1 values. J Pharmacol Exp Ther 251 3238–3246

    Google Scholar 

  • CW Olanow (1992) ArticleTitleMagnetic-resonance-imaging in parkinsonism. Neurol Clin 10 405–420 Occurrence Handle1:STN:280:By2B287lt1M%3D Occurrence Handle1584182

    CAS  PubMed  Google Scholar 

  • PK Randall (1985) ArticleTitleQuantification of dopaminergic supersensitivity using apomorphine induced behaviour in the mouse. Life Sci 37 1419–1423 Occurrence Handle10.1016/0024-3205(85)90081-5 Occurrence Handle1:CAS:528:DyaL2MXlsFCjt70%3D Occurrence Handle4046742

    Article  CAS  PubMed  Google Scholar 

  • PK Randall JA Severson CE Finch (1981) ArticleTitleAging and the regulation of striatal dopaminergic mechanisms in mice. J Pharmacol Exp Ther 219 695–700 Occurrence Handle1:CAS:528:DyaL3MXmtFGitLo%3D Occurrence Handle7197719

    CAS  PubMed  Google Scholar 

  • H Reichmann B Janetzky P Riederer (1995) ArticleTitleIron-dependent enzymes in Parkinson’s disease. J Neural Transm (Suppl) 46 157–164 Occurrence Handle1:CAS:528:DyaK28XitVKht7Y%3D

    CAS  Google Scholar 

  • GP Reynolds JE Brown JE McCall AVP McKay (1992) ArticleTitleDopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a postmortem study. J Neural Transm 87 225–230 Occurrence Handle10.1007/BF01245368 Occurrence Handle1:STN:280:By2B2MrptFA%3D

    Article  CAS  Google Scholar 

  • E Richelson A Elson (1984) ArticleTitleAntagonism of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103 197–214 Occurrence Handle10.1016/0014-2999(84)90478-3 Occurrence Handle1:CAS:528:DyaL2cXls1emu74%3D Occurrence Handle6149136

    Article  CAS  PubMed  Google Scholar 

  • P Riederer E Sofic WD Rausch B Schmidt GP Reynolds K Jellinger MB Youdim (1989) ArticleTitleTransition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52 515–520 Occurrence Handle1:CAS:528:DyaL1MXhtFals78%3D Occurrence Handle2911028

    CAS  PubMed  Google Scholar 

  • Rozenzweig MR, Leiman AL, Breedlove SM, (1999) Biological psychology: an introduction to behavioural, cognitive and clinical neuroscience. Sinauer, Sunderland, MA

  • B Scatton (1977) ArticleTitleDifferential regional development of the tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46 363–369 Occurrence Handle10.1016/0014-2999(77)90230-8 Occurrence Handle1:CAS:528:DyaE1cXhtFGgsrg%3D Occurrence Handle590344

    Article  CAS  PubMed  Google Scholar 

  • N Schroder A Fredriksson M Vianna R Roesler I Izquierdo T Archer (2001) ArticleTitleMemory deficits in adult rats following postnatal iron administration. Behav Brain Res 124 77–85 Occurrence Handle1:CAS:528:DC%2BD3MXksVyltL8%3D Occurrence Handle11423168

    CAS  PubMed  Google Scholar 

  • Strong R, Mattamal M, Andorn A (1993) Free radicals in aging. In: Yu B (ed) Free radicals, the aging brain, and age-related neurodegenerative disorders. CRC Press, Florida, pp 223–246

  • KF Swaiman (1991) ArticleTitleHallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 48 1285–1293 Occurrence Handle1:STN:280:ByyB28zotlE%3D Occurrence Handle1845035

    CAS  PubMed  Google Scholar 

  • D Tarsy RJ Baldessarini (1974) ArticleTitleBehavioural supersensitivity to apomorphine following treatment with drugs which interfere with synaptic function of catecholamines. Neuropharmacology 13 927–940 Occurrence Handle10.1016/0028-3908(74)90084-7 Occurrence Handle1:CAS:528:DyaE2MXmvValtw%3D%3D Occurrence Handle4474641

    Article  CAS  PubMed  Google Scholar 

  • EM Taylor EH Morgan (1990) ArticleTitleDevelopmental changes in transferrin and iron uptake by the brain in the rat. Brain Res Dev Brain Res 55 35–42 Occurrence Handle1:CAS:528:DyaK3cXlt12kur0%3D Occurrence Handle2208639

    CAS  PubMed  Google Scholar 

  • EM Taylor A Crowe EH Morgan (1991) ArticleTitleTransferrin and iron uptake by the brain: effects of altered iron status. J Neurochem 57 1584–1592 Occurrence Handle1:CAS:528:DyaK3MXmsFCrtrs%3D Occurrence Handle1919575

    CAS  PubMed  Google Scholar 

  • JL Waddington (1990) ArticleTitleNeuroleptic/dopamine receptors. Eur J Pharmacol 183 106

    Google Scholar 

  • PF Von Voigtlander EG Losey HF Triezenberg (1975) ArticleTitleIncreased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J Pharmacol Exp Ther 193 88–94 Occurrence Handle1:CAS:528:DyaE2MXktVSks7o%3D

    CAS  Google Scholar 

  • MB Youdim D Ben-Shachar P Riederer (1991) ArticleTitleIron in brain function and dysfunction with emphasis on Parkinson’s disease. Eur Neurol 31 34–40 Occurrence Handle1649757

    PubMed  Google Scholar 

  • MB Youdim D Ben-Shachar P Riederer (1993) ArticleTitleThe possible role of iron in the etiopathology of Parkinson’s disease [published erratum appears in Mov Disord (1993) 8(2): 255]. Mov Disord 8 1–12 Occurrence Handle10.1002/mds.870080102 Occurrence Handle1:STN:280:ByyC38rlvVA%3D Occurrence Handle8419792

    Article  CAS  PubMed  Google Scholar 

  • MB Youdim E Grunblatt S Mandel (1999) ArticleTitleThe pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson’s disease with iron chelators. Ann NY Acad Sci 890 7–25 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCquw%3D%3D Occurrence Handle10668410

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fredriksson, A., Eriksson, P. & Archer, T. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice. J Neural Transm 113, 137–150 (2006). https://doi.org/10.1007/s00702-005-0307-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-005-0307-3

Navigation